Rhythm Pharmaceuticals annual revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Rhythm Pharmaceuticals Revenue Growth & History (RYTM)
Rhythm Pharmaceuticals reported $189.8M in revenue for fiscal 2025, an increase of 45.83% from the previous fiscal year.
View full Rhythm Pharmaceuticals company overviewRhythm Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $189.8M | $59.6M | +45.83% |
| 2024 | 2024-12-31 | $130.1M | $52.7M | +68.06% |
| 2023 | 2023-12-31 | $77.4M | $53.8M | +227.56% |
| 2022 | 2022-12-31 | $23.6M | $20.5M | +649.46% |
| 2021 | 2021-12-31 | $3.2M | $3.2M | — |
| 2020 | 2020-12-31 | $0 | $0 | — |
| 2019 | 2019-12-31 | $0 | $0 | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | — | — |
Rhythm Pharmaceuticals quarterly revenue
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $71.3M | $22.8M | +46.91% |
| Q1 2026 | 2026-03-31 | $60.1M | $27.4M | +83.81% |
| Q4 2025 | 2025-12-31 | $57.3M | $15.4M | +36.87% |
| Q3 2025 | 2025-09-30 | $51.3M | $18.0M | +54.28% |
| Q2 2025 | 2025-06-30 | $48.5M | $19.4M | +66.80% |
| Q1 2025 | 2025-03-31 | $32.7M | $6.7M | +25.94% |
| Q4 2024 | 2024-12-31 | $41.8M | $17.6M | +72.61% |
| Q3 2024 | 2024-09-30 | $33.3M | $10.7M | +47.76% |
| Q2 2024 | 2024-06-30 | $29.1M | $9.9M | +51.28% |
| Q1 2024 | 2024-03-31 | $26.0M | $14.5M | +126.41% |
| Q4 2023 | 2023-12-31 | $24.2M | $15.4M | +175.70% |
| Q3 2023 | 2023-09-30 | $22.5M | $18.2M | +425.30% |
| Q2 2023 | 2023-06-30 | $19.2M | $10.2M | +112.01% |
| Q1 2023 | 2023-03-31 | $11.5M | $10.0M | +665.62% |
| Q4 2022 | 2022-12-31 | $8.8M | $7.0M | +383.76% |
| Q3 2022 | 2022-09-30 | $4.3M | $3.3M | +316.73% |
| Q2 2022 | 2022-06-30 | $9.1M | $8.8M | +3208.76% |
| Q1 2022 | 2022-03-31 | $1.5M | $1.5M | +4180.00% |
| Q4 2021 | 2021-12-31 | $1.8M | — | — |
| Q3 2021 | 2021-09-30 | $1.0M | — | — |
| Q2 2021 | 2021-06-30 | $274,000 | — | — |
| Q1 2021 | 2021-03-31 | $35,000 | — | — |
Rhythm Pharmaceuticals revenue growth trends
Rhythm Pharmaceuticals's latest reported quarter, Q2 2026, generated $71.3M in revenue, an increase of 46.91% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Rhythm Pharmaceuticals source filings ↗